Senolytic Therapeutics Company
Biotechnology company founded in 2016 with operations in Spain (Barcelona) and the US (Boston). Senolytic Therapeutics develops drugs to selectively eliminate senescent cells, which accumulate with age and contribute to chronic inflammation and tissue dysfunction. It is backed by Juvenescenceand academic founders Manuel Serrano and Judith Campisi, two leading scientists in cellular senescence. (senolytx.com)
Estimated Revenue:
No public info
Headquarters:
Barcelona Science Park,Barcelona, Barcelona 08028, Spaim
Employee Number:
5
Number Of Exists:
1-10
Founded Date:
2016